Staunch Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 4.30 Cr
as on 17-07-2024
- Paid Up Capital ₹ 1.95 Cr
as on 17-07-2024
- Company Age 13 Year, 4 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 10.68 Cr
as on 17-07-2024
- Satisfied Charges ₹ 6.07 Cr
as on 17-07-2024
- Revenue -83.07%
(FY 2020)
- Profit -103.03%
(FY 2020)
- Ebitda -863.44%
(FY 2020)
- Net Worth -1333.03%
(FY 2020)
- Total Assets -18.29%
(FY 2020)
About Staunch Pharmaceutical
The Corporate was formerly known as Staunch Pharmaceutical Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 4.30 Cr and a paid-up capital of Rs 1.95 Cr.
The company currently has active open charges totaling ₹10.68 Cr. The company has closed loans amounting to ₹6.07 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Staunch Pharmaceutical Limited India is Shikha Dadhich as CFO. Allarakha Tapali, Rajnikant Dadhich, and Shikha Dadhich serve as directors at the Company.
- CIN/LLPIN
U24239GJ2011PLC065532
- Company No.
065532
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 May 2011
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Staunch Pharmaceutical Limited offer?
Staunch Pharmaceutical Limited offers a wide range of products and services, including Protein Powder, Milk Proteins, Pharma Ingredients & Raw Materials, Blood System and Cardiovascular API, Multivitamin Tablets & Capsules, Antioxidant Capsule, Antibiotic Tablets & Capsules, Azithromycin Tablets, Antibiotic Injection, Piperacillin Tazobactam Injection.
Who are the key members and board of directors at Staunch Pharmaceutical?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shikha Dadhich  | CFO | 03-Sep-2016 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Allarakha Tapali | Director | 09-Aug-2022 | Current |
| Rajnikant Dadhich | Director | 21-May-2011 | Current |
Financial Performance and Corporate Structure Insights of Staunch Pharmaceutical.
Staunch Pharmaceutical Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 83.07% decrease. The company also saw a substantial fall in profitability, with a 103.03% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1333.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Staunch Pharmaceutical?
In 2020, Staunch Pharmaceutical had a promoter holding of 99.99% and a public holding of 0.01%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ethicare Pharmaceuticals Private Limited
Active
31 years 5 months Rajnikant Dadhich is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Sep 2011 | ₹10.68 Cr | Open |
Others Creation Date: 03 Feb 2017 | ₹1.88 Cr | Satisfied |
Dcb Bank Limited Creation Date: 13 Apr 2015 | ₹1.43 Cr | Satisfied |
How Many Employees Work at Staunch Pharmaceutical?
Unlock and access historical data on people associated with Staunch Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Jun 20, 2016, Staunch Pharmaceutical has raised a total of ₹ 1.18 Cr, with the most recent deal valued at ₹ 0.5 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
